Back to EGRX

EAGLE PHARMACEUTICALS, INC. 8-K

Accession 0001104659-22-009232

Filing information

CIK
0000827871
Report date
2022-01-31
Filing date
2022-01-31
Form
8-K
Primary document
tm224831d1_8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.